Can-Fite BioPharma Ltd (CANF):企業の財務・戦略的SWOT分析

◆英語タイトル:Can-Fite BioPharma Ltd (CANF) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH59124FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Can-Fite BioPharma Ltd (Can-Fite) is a clinical stage drug development Company that strives to develop small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheumatoid arthritis and psoriasis; CF102, for hepatocellular carcinoma; and CF602, for erectile dysfunction. Can-Fite develops its products by harnessing its technology platform which is based on the Gi protein associates A3 adenosine receptor (A3AR). The company works in collaboration with pharmaceutical and biotechnology companies to develop its product portfolio. It has operations in Israel and the US. Can-Fite is headquartered in Petah-Tikva, Israel.

Can-Fite BioPharma Ltd Key Recent Developments

Mar 25,2021: Can-Fite Reports 2020 Financial Results & Provides Clinical Development Update
Dec 15,2020: Can-Fite receives Israel Ministry of Health approval to conduct research with cannabinoids in cancer, inflammation and obesity at the company Discovery Labs
Nov 30,2020: Can-Fite Reports Third Quarter 2020 Financial Results & Provides Clinical Update
Nov 30,2020: Can-Fite to Conduct Investor Call to Review Q3 Results and Provide Business Update on Monday, November 30, 2020 at 9:15 a.m. ET 11/23/2020 – 07:00 AM BUSINESS WIRE
Nov 30,2020: Can-Fite reports third quarter 2020 financial results & provides clinical update

This comprehensive SWOT profile of Can-Fite BioPharma Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Can-Fite BioPharma Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Can-Fite BioPharma Ltd – Key Information
Can-Fite BioPharma Ltd – Overview
Can-Fite BioPharma Ltd – Key Employees
Can-Fite BioPharma Ltd – Key Employee Biographies
Can-Fite BioPharma Ltd – Key Operational Heads
Can-Fite BioPharma Ltd – Major Products and Services
Can-Fite BioPharma Ltd – History
Can-Fite BioPharma Ltd – Company Statement
Can-Fite BioPharma Ltd – Locations And Subsidiaries
Can-Fite BioPharma Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Can-Fite BioPharma Ltd – Business Description
Can-Fite BioPharma Ltd – Corporate Strategy
Can-Fite BioPharma Ltd – SWOT Analysis
SWOT Analysis – Overview
Can-Fite BioPharma Ltd – Strengths
Can-Fite BioPharma Ltd – Weaknesses
Can-Fite BioPharma Ltd – Opportunities
Can-Fite BioPharma Ltd – Threats
Can-Fite BioPharma Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Can-Fite BioPharma Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Can-Fite BioPharma Ltd, Key Information
Can-Fite BioPharma Ltd, Key Ratios
Can-Fite BioPharma Ltd, Share Data
Can-Fite BioPharma Ltd, Major Products and Services
Can-Fite BioPharma Ltd, History
Can-Fite BioPharma Ltd, Key Employees
Can-Fite BioPharma Ltd, Key Employee Biographies
Can-Fite BioPharma Ltd, Key Operational Heads
Can-Fite BioPharma Ltd, Other Locations
Can-Fite BioPharma Ltd, Subsidiaries
Can-Fite BioPharma Ltd, Key Competitors
Can-Fite BioPharma Ltd, SWOT Analysis
Can-Fite BioPharma Ltd, Ratios based on current share price
Can-Fite BioPharma Ltd, Annual Ratios
Can-Fite BioPharma Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Can-Fite BioPharma Ltd (CANF):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Votorantim Energia Ltda:企業の戦略的SWOT分析
    Votorantim Energia Ltda - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • ELMOS Semiconductor AG (ELG):企業の財務・戦略的SWOT分析
    ELMOS Semiconductor AG (ELG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ALung Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary ALung Technologies Inc (ALung Technologies) is a medical device company that develops devices for treating patients with acute respiratory failure. The company's Hemolung Respiratory Assist System(RAS) provides respiratory dialysis that removes carbon dioxide and delivers oxygen directly to …
  • Sompo Japan Nipponkoa Holdings, Inc.:企業の戦略・SWOT・財務情報
    Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • ID Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary ID Pharma Co Ltd (ID Pharma), formerly DNAVEC Corp is a manufacturer and commercializer of gene medicines. The company develops regenerative medicines, cell therapy, and other bio products. It offers vector platforms such as Sendai virus vector in its drug development process. ID Pharma’s ve …
  • Tosoh Bioscience Inc:企業の製品パイプライン分析2018
    Summary Tosoh Bioscience Inc (TBI), a subsidiary of Tosoh Corp, is a medical device company that offers diagnostic systems. The company provides analyzers, assays, immunoassay solutions, reagent technology, HbA1c solutions, ß-thalassemia testing, and HPLC technology. Its immunoassay solutions compri …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Beam Suntory Inc.:企業の戦略・SWOT・財務情報
    Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report Summary Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Delphi Automotive Plc (APTV):企業の財務・戦略的SWOT分析
    Delphi Automotive Plc (APTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ADC Therapeutics SA:製薬・医療:M&Aディール及び事業提携情報
    Summary ADC Therapeutics SA (ADCT) is a pharmaceutical company that develops a pipeline of proprietary antibody drug conjugates for the treatment of both solid and hematological cancers. The company offers combining monoclonal antibodies specific to particular types of tumor cells with a novel class …
  • OriGene Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and markets genome research and diagnostic products. OriGene provides products such as qPCR r …
  • Black Hills Corporation:発電所・企業SWOT分析
    Black Hills Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Meridian Bioscience Inc (VIVO)-製薬・医療分野:企業M&A・提携分析
    Summary Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, a …
  • Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析
    Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • The Coca-Cola Co:企業の戦略・SWOT・財務情報
    The Coca-Cola Co - Strategy, SWOT and Corporate Finance Report Summary The Coca-Cola Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Wesfarmers Limited:戦略・SWOT・企業財務分析
    Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report Summary Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Circassia Pharmaceuticals Plc (CIR):医療機器:M&Aディール及び事業提携情報
    Summary Circassia Pharmaceuticals plc (Circassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma. The company’s marketed products include Niox used to assist asthma management and Tudorza for the treatment of chronic obstructive pulmonary disease …
  • Saint-Gobain Ltd:企業の戦略的SWOT分析
    Saint-Gobain Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Logan Resources Ltd:企業の戦略・SWOT・財務情報
    Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Genesis Energy Ltd (GNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Genesis Energy Ltd (Genesis) is an energy company. It generates electricity and supplies that on retail and wholesale basis. The company also supplies gas and LPG, and related services to end-users; and sells and purchases electricity derivatives. Genesis produces power using coal, gas, hydr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆